Differential c‐myc expression profiles in normal human bronchial epithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene‐4,5 epoxide, and benzo[a]pyrene‐7,8‐9,10 diol epoxide
Authors:
- 20 May 2004
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 40 (2) , 79-89
Abstract
Bronchial epithelial cells are often exposed to airborne mutagens that have the potential to induce genetic changes involved in the development of lung cancer. Although lung tumors often display alterations in the expression of oncogenes and/or tumor suppressor genes, the role of specific chemicals and/or metabolites in causing these alterations is not well defined. The polycyclic aromatic hydrocarbon (PAH) benzo[a]pyrene (B[a]P), a by‐product of combustion, is a prevalent airborne environmental mutagen and a constituent of cigarette smoke. The primary objective of this study was to compare the effect of B[a]P and two of its reactive metabolites, benzo[a]pyrene diol epoxide (BPDE or bay region epoxide) and benzo[a]pyrene‐4,5‐dihydroepoxide (BPE or K‐region epoxide), on expression of the proto‐oncogene c‐myc in normal human bronchial epithelial (NHBE) cells using a quantitative reverse transcriptase‐polymerase chain reaction (RT‐PCR) method. Changes in c‐myc gene expression were compared with DNA adduct formation, growth inhibition, and cell‐cycle progression as determined by 32P‐postlabelling, neutral red (NR), and flow cytometric analyses, respectively. None of the three test compounds altered the levels of 18S ribosomal RNA or β‐actin at the concentrations evaluated for c‐myc expression, indicating that nonspecific changes in gene expression induced by cytotoxicity, for example, were not present at the concentrations evaluated. Cells exposed to B[a]P exhibited a dose‐dependent increase in c‐myc expression; conversely, a dose‐dependent decrease in c‐myc expression was observed following BPDE exposure. A marginal but concentration‐dependent increase in c‐myc mRNA levels was observed following exposure to the K‐region epoxide. Our results demonstrated that, although B[a]P and its metabolites alter c‐myc expression, the parent compound and its metabolites produce unequal and contrasting effects on the expression of this gene.Keywords
This publication has 66 references indexed in Scilit:
- Hydrocarbon Carcinogens Evade Cellular Defense Mechanism of G1 Arrest in Nontransformed and Malignant Lung Cell LinesToxicology and Applied Pharmacology, 2001
- Benzo[a]pyrene Activates the Human p53 Gene through Induction of Nuclear Factor κB ActivityJournal of Biological Chemistry, 1999
- DDT Stimulates c-erbB2, c-met, and STATS Tyrosine Phosphorylation, Grb2-Sos Association, MAPK Phosphorylation, and Proliferation of Human Breast Epithelial CellsBiochemical and Biophysical Research Communications, 1997
- Benzo(a)pyrene, but Not 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Alters Cell Proliferation and c-Myc and Growth Factor Expression in Human Placental Choriocarcinoma JEG-3 CellsBiochemical and Biophysical Research Communications, 1997
- Benzo-a-Pyrene: Environmental Partitioning and Human ExposureToxicology and Industrial Health, 1991
- c-myc mRNA is elevated as differentiating lens cells withdraw from the cell cycleExperimental Cell Research, 1987
- Increased stability of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene through interaction with subcellular fractions of rat liverChemico-Biological Interactions, 1987
- General acid catalysis in the hydrolysis of benzo[a]pyrene 7,8-diol 9,10-epoxidesJournal of the American Chemical Society, 1979
- Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cellsNature, 1976
- High mutagenicity and toxicity of a diol epoxide derived from benzo[a]pyreneBiochemical and Biophysical Research Communications, 1976